Dr Keegan has more than 30 years of experience in life science businesses. He was CEO at ForteBio Inc, a life science tool company when it was sold to Pall Corporation. While at the helm he established product development and sales strategies for the company. Prior to that, Dr Keegan was CEO at Molecular Devices Inc (NASDAQ: MDCC), a provider of bioanalytical measurement systems, software and consumables. He is a member of the board of directors of Bio-Techne (NASDAQ: TECH) and Interpace Biosciences Inc (NASDAQ: IDXG). Dr Keegan holds a B.A. in Chemistry from Boston University and a Ph.D. in Physical Chemistry from Stanford University.
George has been a scientific advisor to
Our mission is simple: provide high-quality genes and proteins at your benchtop.Get in touch